# Aspirin Doesn't Prevent Colorectal Cancer, New Review Confirms
A comprehensive review of research has overturned earlier hopes that aspirin could prevent colorectal cancer. The analysis found no consistent evidence that regular aspirin use reduces the risk of developing this disease, despite some previous studies suggesting a protective effect.
Researchers examining decades of clinical trials discovered that while aspirin may lower the risk of certain cancers, colorectal cancer was not among them. The protective effects observed in earlier research appear inconsistent and unreliable when scrutinized across larger datasets.
This finding matters because colorectal cancer remains the second leading cause of cancer deaths in the United States. Many people take aspirin daily for heart health, and the possibility of dual benefits had seemed appealing. However, doctors now advise against using aspirin specifically for cancer prevention.
The evidence does point to other proven strategies for colorectal cancer prevention. Colonoscopy screening catches polyps before they become cancerous and remains the gold standard. People aged 45 to 50 should discuss screening timing with their doctor, depending on personal risk factors.
Diet and lifestyle changes reduce colorectal cancer risk substantially. Eating fiber-rich foods, limiting processed red meat, exercising regularly, maintaining a healthy weight, and limiting alcohol all show clear protective benefits. These approaches address multiple risk factors without the gastrointestinal bleeding risks that long-term aspirin use carries.
For those considering aspirin for heart disease prevention, individual assessment remains essential. The medication carries real bleeding risks that outweigh cancer prevention benefits that don't materialize. People should talk with their healthcare providers about whether aspirin fits their personal cardiovascular risk profile.
The takeaway reflects current medical practice. Colorectal cancer prevention depends on screening, dietary habits, and lifestyle choices rather than aspirin. This clearer evidence helps clinicians and patients make informed